Cargando…

Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals

Systems vaccinology has seldomly been used in therapeutic HIV-1 vaccine research. Our aim was to identify early gene ‘signatures’ that predicted virus load control after analytical therapy interruption (ATI) in participants of a dendritic cell-based HIV-1 vaccine trial (DCV2). mRNA and miRNA were ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fehér, Csaba, Pastor-lbáñez, Roque, Leal, Lorna, Plana, Montserrat, Arnedo, Mireia, van den Ham, Henk-Jan, Andeweg, Arno C., Gruters, Rob A., Díez-Fuertes, Francisco, Alcamí, José, Aloy, Patrick, García, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310264/ https://www.ncbi.nlm.nih.gov/pubmed/34358215 http://dx.doi.org/10.3390/vaccines9070799

Ejemplares similares

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
por: Pastor-Ibáñez, Roque, et al.
Publicado: (2021)

Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment
por: van den Ham, Henk-Jan, et al.
Publicado: (2018)

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
por: Leal, Lorna, et al.
Publicado: (2018)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
por: Esteban, Ignasi, et al.
Publicado: (2021)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
por: Leal, Lorna, et al.
Publicado: (2020)

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)

Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)

High rates of long‐term progression in HIV‐1‐positive elite controllers
por: Borrell, Maria, et al.
Publicado: (2021)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †
por: de Jong, Wesley, et al.
Publicado: (2019)

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
por: Vitallé, Joana, et al.
Publicado: (2017)

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
por: Leal, Lorna, et al.
Publicado: (2021)

MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression
por: Egaña-Gorroño, Lander, et al.
Publicado: (2016)

RTCR: a pipeline for complete and accurate recovery of T cell repertoires from high throughput sequencing data
por: Gerritsen, Bram, et al.
Publicado: (2016)

Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo
por: Stoel, Maaike, et al.
Publicado: (2015)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals
por: Pastor-Ibáñez, Roque, et al.
Publicado: (2021)

The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses
por: Usero, Lorena, et al.
Publicado: (2023)

Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

Analysis of Mouse Brain Transcriptome After Experimental Duvenhage Virus Infection Shows Activation of Innate Immune Response and Pyroptotic Cell Death Pathway
por: Koraka, Penelope, et al.
Publicado: (2018)

Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine
por: Álvarez-Fernández, Carmen, et al.
Publicado: (2012)

Virogenomics: the virus–host interaction revisited
por: Andeweg, Arno C, et al.
Publicado: (2008)

Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
por: Tort, Olivia, et al.
Publicado: (2018)

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4(+) T Cells From HIV-1 Patients
por: Xufré, Cristina, et al.
Publicado: (2022)

Elite controllers long-term non progressors present improved survival and slower disease progression
por: Capa, Laura, et al.
Publicado: (2022)

The Application of Genomics to Emerging Zoonotic Viral Diseases
por: Haagmans, Bart L., et al.
Publicado: (2009)

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection
por: Ayala-Suárez, Rubén, et al.
Publicado: (2020)

Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals
por: Guardo, Alberto Crespo, et al.
Publicado: (2013)

Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
por: Torres, Berta, et al.
Publicado: (2014)

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
por: Badiola, Nahuai, et al.
Publicado: (2013)

Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA
por: Lungu, Cynthia, et al.
Publicado: (2021)

Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus
por: Lim, Stephanie M., et al.
Publicado: (2017)

A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management
por: Fehér, Csaba, et al.
Publicado: (2016)

Sequence analysis of the 3′ end of the feline coronavirus FIPV 79-1146 genome: Comparison with the genome of porcine coronavirus TGEV reveals large insertions
por: De Groot, Raoul J., et al.
Publicado: (1988)

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
por: Climent, Núria, et al.
Publicado: (2019)

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment
por: De Toma, Ilario, et al.
Publicado: (2019)

A15 HIV-1 whole-genome NGS analysis to characterize virus evolution following dendritic cell immunotherapy and analytical treatment interruption
por: Lungu, C, et al.
Publicado: (2018)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors
por: Díez-Fuertes, Francisco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bg39dofip746b2cull1dt0j8lq